X4 Pharmaceuticals, Inc.
USD4.02
+0.03 (+0.75%)
CEO
Adam R. Craig
IPO Date
2017-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.98
Prev. Close
$3.99
Day Low
$3.98
Day High
$4.23
52W Low
$1.35
52W High
$4.83
Market Cap
$0.38B
Volume
8.50M
| 110,000 |
| $4.00 |
| 5 Jan 2026 | de Craecker Francoise | director | A-Award | Acquired | 110,000 | $4.00 |
| 5 Jan 2026 | WYZGA MICHAEL S | director | A-Award | Acquired | 110,000 | $4.00 |
| 5 Jan 2026 | Stewart Murray | director | A-Award | Acquired | 110,000 | $4.00 |
| 31 Oct 2025 | Craig Adam R | director, officer: Executive Chairman | A-Award | Acquired | 2,329,154 | $1.42 |
| 31 Oct 2025 | Volpone John | President | A-Award | Acquired | 2,329,154 | $1.42 |
| 31 Oct 2025 | KIRSKE DAVID | Chief Financial Officer | A-Award | Acquired | 1,552,769 | $1.42 |
| 27 Oct 2025 | Craig Adam R | director, officer: Executive Chairman | P-Purchase | Acquired | 86,206 | $2.90 |
| 14 Aug 2025 | Volpone John | President | A-Award | Acquired | 289,881 | $0.00 |